Filing Details
- Accession Number:
- 0001209191-19-046731
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2019-08-19 19:55:54
- Reporting Period:
- 2019-02-19
- Accepted Time:
- 2019-08-19 19:55:54
- Original Submission Date:
- 2019-02-21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1131324 | Genomic Health Inc | GHDX | Services-Medical Laboratories (8071) | 770552594 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1649199 | W. Jason Radford | 301 Penobscot Dr. Redwood City CA 94063 | Chief Legal Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-02-19 | 2,889 | $83.03 | 31,787 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-02-19 | 619 | $83.73 | 31,168 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on November 15, 2018.
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- Represents weighted average sale price. Actual sale prices ranged from $82.59 to $83.58.
- Includes an aggregate of 20,924 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- Represents weighted average sale price. Actual sale prices ranged from $83.63 to $83.97.
Billionaire Hedge Funds
